Opening stock page...
Fetching company snapshot, pricing, and intelligence.
Opening stock page...
Fetching company snapshot, pricing, and intelligence.
Intelligence coverage: 60%
Basic profile, financials, and market data are shown below. Deep research is building in the background.
AI confidence 65% · prior close shown (market closed)
Limited proprietary earnings coverage for EBS yet — signals will sharpen as filings and earnings are ingested.
Pipeline evidence · 33d ago
Reported figures for Emergent BioSolutions Inc. — research only, not investment advice.
Updated
What happened recently for Emergent BioSolutions Inc. (EBS) — events, not interpretation.
Research & analysis only — not investment advice.
Investment snapshot
Prior close
$4.49
Market cap
$230.22M
Profitable
Yes
Revenue $742.90M
Net income
$52.60M
FY Dec 31, 2025
Loading Wall Street consensus…
Loading earnings intelligence…
Building technical intelligence snapshot — check back shortly.
Loading market context…
No price history. Sync market data to load charts.
Loading SEC filing intelligence…
No filings ingested yet.
Investment Snapshot above is the primary AlphaOS analysis for Emergent BioSolutions Inc. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.
Research & analysis only — not investment advice. Price, charts, and filings are above.
Connected companies and research pages from the AlphaOS knowledge graph.
Follow Emergent BioSolutions Inc. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.